Literature DB >> 32691833

Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance.

Jeffrey R Strich1,2, Emily L Heil3, Henry Masur1.   

Abstract

Patients with sepsis present across a spectrum of infection sites and severity of illnesses requiring complex decision making at the bedside as to when prompt antibiotics are indicated and which regimen is warranted. Many hemodynamically stable patients with sepsis and low acuity of illness may benefit from further work up before initiating therapy, whereas patients with septic shock warrant emergent broad-spectrum antibiotics. The precise empiric regimen is determined by assessing patient and epidemiological risk factors, likely source of infection based on presenting signs and symptoms, and severity of illness. Hospitals should implement quality improvement measures to aid in the rapid and accurate diagnosis of septic patients and to ensure antibiotics are given to patients in an expedited fashion after antibiotic order. Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Entities:  

Keywords:  antimicrobial resistance; empiric antibiotics; sepsis; septic shock

Mesh:

Substances:

Year:  2020        PMID: 32691833      PMCID: PMC7372215          DOI: 10.1093/infdis/jiaa221

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  81 in total

1.  Empiric Antibiotic Treatment Thresholds for Serious Bacterial Infections: A Scenario-based Survey Study.

Authors:  Alex M Cressman; Derek R MacFadden; Amol A Verma; Fahad Razak; Nick Daneman
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

Review 2.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

3.  Improving door-to-antibiotic time in severely septic emergency department patients.

Authors:  Eveline A Hitti; John J Lewin; Jose Lopez; Jonathan Hansen; Michael Pipkin; Taha Itani; Paul Gurny
Journal:  J Emerg Med       Date:  2011-07-07       Impact factor: 1.484

4.  Frequency of microbiologically correct antibiotic therapy increased by infectious disease consultations and microbiological results.

Authors:  J J Kerremans; H A Verbrugh; M C Vos
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

5.  Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.

Authors:  M Giannella; E M Trecarichi; F G De Rosa; V Del Bono; M Bassetti; R E Lewis; A R Losito; S Corcione; C Saffioti; M Bartoletti; G Maiuro; C S Cardellino; S Tedeschi; R Cauda; C Viscoli; P Viale; M Tumbarello
Journal:  Clin Microbiol Infect       Date:  2014-08-11       Impact factor: 8.067

6.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

7.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

8.  Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.

Authors:  Abraham Borer; Lisa Saidel-Odes; Seada Eskira; Ronit Nativ; Klaris Riesenberg; Ilana Livshiz-Riven; Francisc Schlaeffer; Michael Sherf; Nejama Peled
Journal:  Am J Infect Control       Date:  2011-09-09       Impact factor: 2.918

9.  Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies.

Authors:  Patricia Cornejo-Juárez; Juan Antonio Suárez-Cuenca; Patricia Volkow-Fernández; Jesús Silva-Sánchez; Humberto Barrios-Camacho; Esmeralda Nájera-León; Consuelo Velázquez-Acosta; Diana Vilar-Compte
Journal:  Support Care Cancer       Date:  2015-05-27       Impact factor: 3.603

10.  Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa.

Authors:  Jason M Pogue; Keith S Kaye; Michael P Veve; Twisha S Patel; Anthony T Gerlach; Susan L Davis; Laura A Puzniak; Tom M File; Shannon Olson; Sorabh Dhar; Robert A Bonomo; Federico Perez
Journal:  Clin Infect Dis       Date:  2020-07-11       Impact factor: 9.079

View more
  14 in total

Review 1.  Medication and Fluid Management of Pediatric Sepsis and Septic Shock.

Authors:  Lauren Burgunder; Caroline Heyrend; Jared Olson; Chanelle Stidham; Roni D Lane; Jennifer K Workman; Gitte Y Larsen
Journal:  Paediatr Drugs       Date:  2022-03-21       Impact factor: 3.022

2.  Clinical Significance of BD Bactec FX Blood Culture Incubation Beyond 96 Hours (4 Days).

Authors:  Patrizia Sophia Ulrich; Ingmar N Bastian; Derrick J Chen
Journal:  J Clin Microbiol       Date:  2022-06-27       Impact factor: 11.677

3.  Digital imaging for reading of direct rapid antibiotic susceptibility tests from positive blood cultures.

Authors:  Gina K Thomson; Kira Jamros; James W Snyder; Kenneth S Thomson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-25       Impact factor: 3.267

4.  An Observational Cohort Study Evaluating Antimicrobial Use in Peripartum Sepsis: A Tendency towards Overdiagnosis?

Authors:  Nouf Abutheraa; June Grant; Alexander B Mullen
Journal:  Pharmacy (Basel)       Date:  2020-11-11

5.  Antimicrobial Use in Companion Animals: Assessing Veterinarians' Prescription Patterns through the First National Survey in Chile.

Authors:  Nicolás Galarce; Gabriel Arriagada; Fernando Sánchez; Vladimir Venegas; Javiera Cornejo; Lisette Lapierre
Journal:  Animals (Basel)       Date:  2021-01-30       Impact factor: 2.752

6.  Multidrug-Resistant Healthcare-Associated Infections in Neonates with Severe Respiratory Failure and the Impacts of Inappropriate Initial Antibiotic Therap.

Authors:  Jen-Fu Hsu; Shih-Ming Chu; Hsiao-Chin Wang; Chen-Chu Liao; Mei-Yin Lai; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Ming-Horng Tsai
Journal:  Antibiotics (Basel)       Date:  2021-04-18

Review 7.  Antimicrobial Therapy in Pediatric Sepsis: What Is the Best Strategy?

Authors:  Luciana Becker Mau; Vera Bain
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

8.  Performance of the eazyplex® BloodScreen GN as a simple and rapid molecular test for identification of Gram-negative bacteria from positive blood cultures.

Authors:  Katharina Bach; Birgit Edel; Steffen Höring; Lucie Bartoničkova; Stefan Glöckner; Bettina Löffler; Christina Bahrs; Jürgen Rödel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-11-22       Impact factor: 3.267

9.  Weaning of septic patients from the ventilator in the intensive care unit by attention approach to common antibiotic regimens.

Authors:  Mohammad J Sadegh; Mohammadreza Rafiei; Ebrahim Hazrati; Mehrshad Namazi; Mohammad Afsahi
Journal:  J Family Med Prim Care       Date:  2022-03-10

10.  The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients.

Authors:  Mabel Duarte Alves Gomides; Astrídia Marília de Souza Fontes; Amanda Oliveira Soares Monteiro Silveira; Daniel Chadud Matoso; Anderson Luiz Ferreira; Geraldo Sadoyama
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.